Affiliated Hospital of Nantong University | China
Author Profile
Scopus
📚 EARLY ACADEMIC PURSUITS
Dr. Ding Weifeng embarked on his academic journey with a strong foundation in medical laboratory science. His dedication to excellence and a deep interest in clinical research paved the way for advanced education, culminating in a Ph.D. His academic rigor was further enriched during his tenure as a Senior Visiting Scholar at the University of Texas Health Science Center (UTH) in the United States, where he gained international exposure and expertise.
🏆 PROFESSIONAL ENDEAVORS
Currently, Dr. Ding serves as the Deputy Director of the Department of Clinical Laboratory at the Affiliated Hospital of Nantong University and the Deputy Director of the Department of Laboratory Medicine at Nantong University. He holds dual roles as Chief Technologist, Associate Professor, and Master’s Supervisor, combining practical expertise, teaching, and mentorship in his field.
His professional career reflects significant recognition as a high-level talent under Jiangsu Province's "333" Project, a leading figure in Nantong City's "226" Project, and a key young medical talent in Jiangsu Province.
🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON PANCREATIC CANCER
Dr. Ding's research expertise spans medical laboratory science, with significant contributions in:
- Advancing laboratory diagnostics.
- Innovating approaches to translational medicine and molecular techniques.
He has successfully led three National Natural Science Foundation projects, a China Postdoctoral Science Foundation project, and seven provincial and municipal research projects. These projects demonstrate his ability to bridge clinical applications and theoretical research.
🌍 IMPACT AND INFLUENCE
Dr. Ding has gained widespread recognition for his contributions to scientific research, including the:
- Third Prize of Jiangsu Medical Science and Technology Award
- Second Prize of Nantong Science and Technology Progress Award
- Nantong Youth Science and Technology Award
His achievements underscore his impact on the fields of clinical practice and scientific innovation.
📈 ACADEMIC CITATIONS AND SCHOLARLY IMPACT
Dr. Ding has authored nearly 30 SCI-indexed papers as the first or corresponding author, reflecting his leadership and originality in research. Furthermore, his five Chinese invention patents attest to his contributions to technological advancements in medical diagnostics.
🌟 LEGACY AND FUTURE CONTRIBUTIONS
Dr. Ding’s dedication to medical laboratory science has left a lasting legacy in education, innovation, and clinical practice. He actively fosters the next generation of professionals through mentorship and collaboration while pushing the frontiers of translational medicine and diagnostic technology.
In the years ahead, he is expected to:
- Strengthen collaborations across global institutions.
- Expand research projects in cutting-edge medical technologies.
- Continue mentoring aspiring professionals in the medical laboratory field.
🌐 ENGAGEMENT IN ACADEMIC ORGANIZATIONS
Dr. Ding is actively involved in professional communities:
- Standing Committee Member of the Abdominal Tumor Comprehensive Rehabilitation Branch, China Medical Education Association.
- Committee Member of the Translational Medicine Professional Committee, Jiangsu Immunology Society.
- Member of the Clinical Molecular Group, Jiangsu Medical Association Laboratory Medicine Branch.
📑NOTABLE PUBLICATIONS
"Combined ultrasound endoscopy-guided fine-needle aspiration with DNA methylation of SHOX2 and RASSF1A genes to enhance the auxiliary diagnostic precision of pancreatic cancer"
- Authors: Shan, Y. , Teng, Y. , Guan, C. , Ding, W. , Zhang, J.
- Journal: Heliyon
- Year: 2024
"DNA methylation modulates epigenetic regulation in colorectal cancer diagnosis, prognosis and precision medicine"
- Authors: Ye, J., Zhang, J., Ding, W.
- Journal: Exploration of Targeted Anti-tumor Therapy
- Year: 2024
"Retraction Note: Targeting of colorectal cancer growth, metastasis, and anti-apoptosis in BALB/c nude mice via APRIL siRNA (Molecular and Cellular Biochemistry"
- Authors: Wang, J. , Ding, W. , Sun, B. , Shi, G. , Wang, H.
- Journal: Molecular and Cellular Biochemistry
- Year: 2023
"DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter "
- Authors: Shao, K. , Pu, W. , Zhang, J. , Zhang, Z. , Ding, W.
- Journal: Clinical Epigenetics
- Year: 2021
"Targeted Bisulfite Sequencing Reveals DNA Methylation Changes in Zinc Finger Family Genes Associated With KRAS Mutated Colorectal Cancer"
- Authors: Pu, W. , Qian, F. , Liu, J. , Ju, S. , Ding, W.
- Journal: Frontiers in Cell and Developmental Biology
- Year: 2021